Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Gold

Showing results (41-50 of 381) with videos related to

Pageof 39
Sort By:
JACC. Asia|January 10, 2023
Improving Primary Prevention of SCD With ICDs in Asia: One Size Does Not Fit All!Chau N Vo, Michael R Gold
Cardiology Clinics|June 10, 2008
Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden deathMatthew H Klein, Michael R Gold
Nature Reviews. Cardiology|October 3, 2012
Is defibrillation testing of ICDs necessary?J Lacy Sturdivant, Michael R Gold
Frontiers in Immunology|September 1, 2012
Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignanciesKamal D Puri, Michael R Gold
Cardiac Electrophysiology Clinics|March 5, 2016
Defibrillation Threshold Testing: Who Doesn't Get It?Frank A Cuoco, Michael R Gold
Arrhythmia & Electrophysiology Review|February 3, 2016
Developments in Cardiac Resynchronisation TherapyGeoffrey F Lewis, Michael R Gold
Trends in Cardiovascular Medicine|November 21, 2019
Editorial commentary: The subcutaneous ICD: An expanding niche or the future of implantable defibrillators?Adam R Bainey, Michael R Gold
Annual Review of Immunology|April 27, 2019
Antigen Receptor Function in the Context of the Nanoscale Organization of the B Cell MembraneMichael R Gold, Michael G Reth
JACC. Clinical Electrophysiology|September 21, 2019
Optimization of Cardiac Resynchronization Therapy: Should Perioperative Hemodynamic Measurements Be Routine?Joshua E Payne, Michael R Gold
Heart Failure Clinics|March 29, 2011
Economic implications and cost-effectiveness of implantable cardioverter defibrillator and cardiac resynchronization therapyMichael L Bernard, Michael R Gold
Pageof 39

Showing results (41-50 of 381) with videos related to

Sort By:
Pageof 39
JACC. Asia|January 10, 2023
Improving Primary Prevention of SCD With ICDs in Asia: One Size Does Not Fit All!Chau N Vo, Michael R Gold
Cardiology Clinics|June 10, 2008
Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden deathMatthew H Klein, Michael R Gold
Nature Reviews. Cardiology|October 3, 2012
Is defibrillation testing of ICDs necessary?J Lacy Sturdivant, Michael R Gold
Frontiers in Immunology|September 1, 2012
Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignanciesKamal D Puri, Michael R Gold
Cardiac Electrophysiology Clinics|March 5, 2016
Defibrillation Threshold Testing: Who Doesn't Get It?Frank A Cuoco, Michael R Gold
Arrhythmia & Electrophysiology Review|February 3, 2016
Developments in Cardiac Resynchronisation TherapyGeoffrey F Lewis, Michael R Gold
Trends in Cardiovascular Medicine|November 21, 2019
Editorial commentary: The subcutaneous ICD: An expanding niche or the future of implantable defibrillators?Adam R Bainey, Michael R Gold
Annual Review of Immunology|April 27, 2019
Antigen Receptor Function in the Context of the Nanoscale Organization of the B Cell MembraneMichael R Gold, Michael G Reth
JACC. Clinical Electrophysiology|September 21, 2019
Optimization of Cardiac Resynchronization Therapy: Should Perioperative Hemodynamic Measurements Be Routine?Joshua E Payne, Michael R Gold
Heart Failure Clinics|March 29, 2011
Economic implications and cost-effectiveness of implantable cardioverter defibrillator and cardiac resynchronization therapyMichael L Bernard, Michael R Gold
Pageof 39